Aaron Wealth Advisors LLC Cuts Stock Position in Danaher Corporation $DHR

Aaron Wealth Advisors LLC reduced its position in Danaher Corporation (NYSE:DHRFree Report) by 3.6% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,172 shares of the conglomerate’s stock after selling 267 shares during the quarter. Aaron Wealth Advisors LLC’s holdings in Danaher were worth $1,417,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of DHR. Bank Pictet & Cie Europe AG boosted its holdings in shares of Danaher by 22.8% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 192,731 shares of the conglomerate’s stock worth $44,241,000 after purchasing an additional 35,730 shares in the last quarter. Strategic Wealth Partners Ltd. boosted its holdings in shares of Danaher by 14.4% in the 4th quarter. Strategic Wealth Partners Ltd. now owns 1,502 shares of the conglomerate’s stock worth $345,000 after purchasing an additional 189 shares in the last quarter. Woodline Partners LP boosted its holdings in shares of Danaher by 5.5% in the 4th quarter. Woodline Partners LP now owns 414,771 shares of the conglomerate’s stock worth $95,211,000 after purchasing an additional 21,471 shares in the last quarter. Waverly Advisors LLC boosted its holdings in shares of Danaher by 24.8% in the 4th quarter. Waverly Advisors LLC now owns 10,596 shares of the conglomerate’s stock worth $2,432,000 after purchasing an additional 2,109 shares in the last quarter. Finally, Worldquant Millennium Advisors LLC purchased a new position in shares of Danaher in the 4th quarter worth about $1,993,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

DHR has been the subject of several analyst reports. Robert W. Baird increased their target price on Danaher from $225.00 to $226.00 and gave the company an “outperform” rating in a report on Friday, July 18th. UBS Group dropped their target price on Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a report on Wednesday, July 23rd. Guggenheim restated a “buy” rating and set a $250.00 target price on shares of Danaher in a report on Wednesday, July 23rd. Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a report on Friday, June 27th. Finally, Barclays restated an “overweight” rating and set a $225.00 target price (up from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Seventeen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $246.35.

Get Our Latest Report on Danaher

Danaher Stock Up 1.0%

DHR stock opened at $190.43 on Wednesday. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $279.90. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The firm has a market cap of $136.36 billion, a PE ratio of 40.52, a price-to-earnings-growth ratio of 2.63 and a beta of 0.75. The business has a 50 day moving average of $200.77 and a 200 day moving average of $198.59.

Danaher (NYSE:DHRGet Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. The company had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The firm’s revenue for the quarter was up 3.4% on a year-over-year basis. During the same quarter last year, the company earned $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, research analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.7%. Danaher’s payout ratio is presently 27.23%.

Insider Activity at Danaher

In related news, Director Teri List sold 2,778 shares of Danaher stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director owned 20,751 shares of the company’s stock, valued at $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 11.20% of the stock is owned by insiders.

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.